RAPID-Dx Workshop: Best Practices and Technologies for Biomarker Discovery and Development

RAPID-Dx Workshop: Best Practices and Technologies for Biomarker Discovery and Development

May 6-7, 2019 – Cambridge, MA

RAPID-Dx - Research Alliance for PTSD/TBI Innovation & Discovery DiagnosticsThe workshop sponsored by RAPID-Dx (Research Alliance for PTSD/TBI Innovation & Discovery Diagnostics) will convene experts from academia, government, and industry to discuss technological platforms for advancing biomarker discovery and development in PTSD and clinical co-presentations.

Over the course of four panel discussions on distinct biomarker modalities, we will assess the current research landscape around candidate and novel biomarkers of trauma-related brain disorders. Discussions will center on the available technological platforms and assays for each biomarker modality, including on-going efforts for standardization and harmonization.

The program will include presentations from leaders in the field followed by in-depth discussions to address Workshop Objectives, which include:

  1. Reviewing the research landscape and prioritizing current biomarker in the context of clinical applications (“indications of use”) of these biomarkers
  2. Discussing best-practices and the scalability of biomarker modalities for developing biological mechanism-based classifications (taxonomy) of disease, improving diagnostic efforts, and predicting treatment response
  3. Prioritizing candidate biomarkers/platforms that meet technical readiness levels for replication and/or validation and discussing the need for assay comparison efforts

Proceedings from the workshop will be prepared and made available to the research community for feedback and future roadmap development.

Learn more about RAPID-Dx